Whittier Trust’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-625
Closed -$275 1629
2023
Q1
$275 Hold
625
﹤0.01% 1574
2022
Q4
$131 Hold
625
﹤0.01% 1603
2022
Q3
$0 Hold
625
﹤0.01% 1799
2022
Q2
$0 Hold
625
﹤0.01% 1809
2022
Q1
$1K Hold
625
﹤0.01% 1697
2021
Q4
$1K Hold
625
﹤0.01% 1568
2021
Q3
$2K Hold
625
﹤0.01% 1440
2021
Q2
$2K Hold
625
﹤0.01% 1472
2021
Q1
$2K Sell
625
-625
-50% -$3.48K ﹤0.01% 1466
2020
Q4
$6K Buy
1,250
+625
+100% +$3.23K ﹤0.01% 1231
2020
Q3
$3K Hold
625
﹤0.01% 1312
2020
Q2
$2K Hold
625
﹤0.01% 1313
2020
Q1
$3K Hold
625
﹤0.01% 1321
2019
Q4
$3K Buy
+625
New +$3.05K ﹤0.01% 1340

Other funds holding CEMI

Whittier Trust's CEMI Position: Q2 2023 in Review

Whittier Trust sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 625 shares — an estimated $275 sold.

Whittier Trust first reported a position in CEMI in Q4 2019 and held it in 14 quarters. The position peaked at $6K in Q4 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

  • Whittier Trust reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
  • Whittier Trust sold 625 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $275.
  • Whittier Trust first reported a position in Chembio diagnostics, Inc. in Q4 2019 and held it in 14 quarters.
  • Whittier Trust's Chembio diagnostics, Inc. position peaked at $6K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on Whittier Trust's 13F filing for Q2 2023, filed 24 Jul 2023.